Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Stent containing CD44-targeting polymeric prodrug nanoparticles that release paclitaxel and gemcitabine in a time interval-controlled manner for synergistic human biliary cancer therapy
Dayeon
Yun
a,
Hyun-Ouk
Kim
a,
Hye Young
Son
b,
Yuna
Choi
b,
Ilkoo
Noh
c,
Jong-Woo
Lim
a,
Jihye
Kim
a,
Haejin
Chun
a,
Geunseon
Park
a,
Dong Ki
Lee
d,
Sung Il
Jang
d,
Eunji
Jang
b,
Yong-Min
Huh
*b and
Seungjoo
Haam
*a
aDepartment of Chemical and Biomolecular Engineering, Yonsei University, Seoul 120-749, Republic of Korea. E-mail: haam@yonsei.ac.kr
bDepartment of Radiology, Yonsei University, Seoul 120-752, Republic of Korea. E-mail: ymhuh@yuhs.ac
cDepartment of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejon 305-701, Republic of Korea
dDepartment of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, 712 Eonjuro, Gangnam-Gu, Seoul 135-720, Republic of Korea
First published on 7th November 2017
Abstract
Correction for ‘Stent containing CD44-targeting polymeric prodrug nanoparticles that release paclitaxel and gemcitabine in a time interval-controlled manner for synergistic human biliary cancer therapy’ by Dayeon Yun et al., J. Mater. Chem. B, 2017, 5, 6317–6324.
The following text was omitted from the Acknowledgements section of the published article:
This work was also supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (NRF-2015M3A9D7029878 and NRF-2015M3A7B6027963).
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2017 |